Circulating SERPINA3 improves prognostic stratification in patients with a de novo or worsened heart failure.
Sign Up to like & getrecommendations! Published in 2021 at "ESC heart failure"
DOI: 10.1002/ehf2.13659
Abstract: AIMS We investigated the prognostic relevance of serpin peptidase inhibitor, clade A member 3 (SERPINA3) in patients admitted with a de novo or worsened heart failure (HF). METHODS AND RESULTS In the first stage, 83… read more here.
Keywords: circulating serpina3; serpina3 levels; heart failure; novo worsened ... See more keywords
Circulating Serpina3 levels predict the major adverse cardiac events in patients with myocardial infarction.
Sign Up to like & getrecommendations! Published in 2019 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2019.08.034
Abstract: BACKGROUND Serine proteinase inhibitor A3 (Serpina3), initially discovered as an acute phase plasma protease inhibitor, has been demonstrated in the pathology of complex human disorders, but it is yet to be discovered following acute myocardial… read more here.
Keywords: serpina3; serpina3 levels; mace; myocardial infarction ... See more keywords